Ascendis Pharma A/S (ASND)

Ascendis Pharma Revenue

Ascendis Pharma had revenue of 36.00M EUR in the quarter ending June 30, 2024, a decrease of -24.04%. This brings the company's revenue in the last twelve months to 317.63M, up 166.54% year-over-year. In the year 2023, Ascendis Pharma had annual revenue of 266.72M with 421.20% growth.

• Revenue (ttm): 317.63M EUR
• Revenue Growth: +166.54%
• P/S Ratio: 21.30
• Revenue / Employee: 361,352 EUR
• Employees: 879
• Market Cap: 7.53B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	266.72M	215.54M	421.20%
Dec 31, 2022	51.17M	43.40M	557.93%
Dec 31, 2021	7.78M	825.00K	11.87%
Dec 31, 2020	6.95M	-6.42M	-48.01%
Dec 31, 2019	13.38M	2.79M	26.41%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.